Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Illumina Leaves Mission Bay for New Campus in the Peninsula

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

The new campus will consolidate some 400 employees in one place and give more space to the startup companies it helps. Source: BioSpace

Continue ReadingIllumina Leaves Mission Bay for New Campus in the Peninsula

Superstar Investors Jump in on Celgene Spinout Celularity's $250M Funding Round

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

Celularity is a biotech founded by stem cell pioneer Robert Hariri, MD, PhD. Source: BioSpace

Continue ReadingSuperstar Investors Jump in on Celgene Spinout Celularity's $250M Funding Round

FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form. Source: BioSpace

Continue ReadingFDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros

Officials Eye New Biotech Tenants for Bristol-Myers' Former Connecticut Complex

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

This week MA-based real estate firm Calare Properties acquired the land and buildings for $5M. Source: BioSpace

Continue ReadingOfficials Eye New Biotech Tenants for Bristol-Myers' Former Connecticut Complex

Merck KGaA, Pfizer's Lung Cancer Drug Flunks Late-Stage Trial

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

Detailed results from the JAVELIN Lung 200 trial will be submitted for presentation at an upcoming medical congress. Source: BioSpace

Continue ReadingMerck KGaA, Pfizer's Lung Cancer Drug Flunks Late-Stage Trial

Drug Giant Roche Buys Former Google Execs' Flatiron in $1.9B Deal

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

Roche will plunk down $1.9M to acquire Flatiron Health, which has previously been backed by GV, as well as Roche. Source: BioSpace

Continue ReadingDrug Giant Roche Buys Former Google Execs' Flatiron in $1.9B Deal

Why Novavax Could be a Millionaire-Maker Stock

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

If you had a crystal ball, you probably would have invested in Berkshire Hathaway in 1964, or Apple in the 1980s. Source: BioSpace

Continue ReadingWhy Novavax Could be a Millionaire-Maker Stock

2 Biotechs With the Potential of Doubling Investors' Cash

  • Post author:Sam
  • Post published:February 14, 2018
  • Post category:BioPharma

Analyst price targets for these two biotechs suggest they could double your money. Here's what you need to know. Source: BioSpace

Continue Reading2 Biotechs With the Potential of Doubling Investors' Cash

Oxford BioMedica Wins $105M Gene Therapy Contract From Bioverativ

  • Post author:Sam
  • Post published:February 14, 2018
  • Post category:BioPharma

The deal includes a licence to use OXB's LentiVector Enabled technology and access to its industrial-scale manufacturing technology. Source: BioSpace

Continue ReadingOxford BioMedica Wins $105M Gene Therapy Contract From Bioverativ

Beleaguered Axovant Begins Cutting Jobs While Exiting CEO Gets $2.6M+ Severance Package

  • Post author:Sam
  • Post published:February 14, 2018
  • Post category:BioPharma

When David Hung abruptly left Axovant Sciences this week, he walked away with a hefty severance package of $2.26M as well as a discretionary bonus of $300,000, according to a…

Continue ReadingBeleaguered Axovant Begins Cutting Jobs While Exiting CEO Gets $2.6M+ Severance Package
  • Go to the previous page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.